## Note
nid: 1483845020612
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Neurology::Neuro_Misc, #AK_Step1_v11::#FirstAid::12_Neuro_&_Special_Senses::02_Anatomy_&_Physiology::19_Dopaminergic_Pathways, #AK_Step1_v11::#FirstAid::12_Neuro_&_Special_Senses::02_Anatomy_&_Physiology::19_Dopaminergic_Pathways::Mesolimbic, #AK_Step1_v11::#OME_banner::Clinical::10_Neurology, #AK_Step1_v11::#UWorld::10000-99999::15000-15999::15327, #AK_Step1_v11::^Other::^EXPN::BGedit, #AK_Step1_v11::^Other::^EXPN::Uworld, #AK_Step1_v11::^Systems::Neuro::neurology, #AK_Step1_v11::^Systems::Neuro::neuroscience, #AK_Step2_v11::#B&B::03_Psych::04_Psychopharmacology::02_Antipsychotics::01_Dopamine_hypothesis, #AK_Step2_v11::#OME::12_Psychiatry::07_Psychosis, #AK_Step2_v11::#OME::12_Psychiatry::15_Pharm_2
markdown: false

### Text
<div>
  Which <u>dopaminergic pathway</u> is the primary target for the
  <b>antipsychotic</b> <b>treatment</b> of <b>schizoprenia</b>?
</div>
<div>
  {{c1::Mesolimbic pathway}}
</div>

### Extra
<i>antipsychotics exert their actions via <u>inhibition</u> of the
mesolimbic pathway; stimulation of mesolimbic pathway -->
"positive" symptoms</i>
<div>
  <i><img src="paste-43383464656897.jpg"></i>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="tmpYGim8Z.png">

### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/neurology?ref=anki"><img src="_OME_AnkiFlashcards_Topic_4.png"></a>
</div>

### Additional Resources


### One by one

